Craig W. Lindsley joined Vanderbilt University in 2006, where he holds the position of Director of Medicinal Chemistry. His work focuses mainly on the development of allosteric modulators of GPCRs for the treatment of various diseases. This Investigator also serves as a reviewer for a large number of journals and is currently Editor-in-Chief of ACS Chemical Neuroscience.